Novo Nordisk A/S ADR buy Sanford C. Bernstein
Start price
09.09.25
/
50%
€45.85
Target price
09.09.26
-
Performance (%)
-15.03%
Price
19.06.26
€38.96
Summary
This prediction is currently active. The price of Novo Nordisk A/S ADR has decreased since the start of the prediction. Compared to the start price this results in a performance of -15.03%. This prediction currently runs until 09.09.26. The prediction end date can be changed by Sanford_C__Bernstein at any time. Sanford_C__Bernstein has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Novo Nordisk A/S ADR | 2.688% | 2.688% |
| iShares Core DAX® | 1.352% | 2.740% |
| iShares Nasdaq 100 | 3.277% | 6.507% |
| iShares Nikkei 225® | 7.434% | 17.832% |
| iShares S&P 500 | 1.702% | 3.099% |
Comments by Sanford_C__Bernstein for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
Novo Nordisk A/S (NYSE:NVO) was upgraded by analysts at Sanford C. Bernstein from a "market perform" rating to an "outperform" rating.
Ratings data for NVO provided by MarketBeat
Stopped prediction by Sanford_C__Bernstein for Novo Nordisk A/S ADR
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€32.60
18.03.26
18.03.26
€151.71
18.03.27
18.03.27
19.51%
19.06.26
19.06.26
